EdgarLookup

AXIS CAPITAL HOLDINGS LTD — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that AXIS CAPITAL HOLDINGS LTD filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
15.4%
Profit Margin
Net income ÷ revenue
2.9%
Return on Assets
Net income ÷ assets
4.42x
Debt-to-Equity
Total liabilities ÷ equity
+10.2%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.56B Feb 27, 2026
FY2025 Dec 31, 2024 $5.96B Feb 27, 2026
FY2025 Dec 31, 2023 $5.64B Feb 27, 2026
FY2024 Dec 31, 2022 $5.14B Feb 26, 2025
FY2023 Dec 31, 2021 $5.32B Feb 27, 2024
FY2022 Dec 31, 2020 $4.84B Feb 27, 2023
FY2021 Dec 31, 2019 $5.17B Feb 25, 2022
FY2020 Dec 31, 2018 $5.09B Feb 26, 2021
FY2019 Dec 31, 2017 $4.59B Feb 27, 2020
FY2018 Dec 31, 2016 $4.01B Feb 26, 2019

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $32.00M Feb 26, 2019

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.01B Feb 27, 2026
FY2025 Dec 31, 2024 $1.08B Feb 27, 2026
FY2025 Dec 31, 2023 $376.29M Feb 27, 2026
FY2024 Dec 31, 2022 $223.08M Feb 26, 2025
FY2023 Dec 31, 2021 $618.61M Feb 27, 2024
FY2022 Dec 31, 2020 ($120.42M) Feb 27, 2023
FY2021 Dec 31, 2019 $323.47M Feb 25, 2022
FY2020 Dec 31, 2018 $43.02M Feb 26, 2021
FY2019 Dec 31, 2017 ($368.97M) Feb 27, 2020
FY2018 Dec 31, 2016 $513.37M Feb 26, 2019

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $703.93M Feb 27, 2026
FY2025 Dec 31, 2024 $666.20M Feb 27, 2026
FY2025 Dec 31, 2023 $684.45M Feb 27, 2026
FY2024 Dec 31, 2022 $680.34M Feb 26, 2025
FY2023 Dec 31, 2021 $663.30M Feb 27, 2024
FY2022 Dec 31, 2020 $579.79M Feb 27, 2023
FY2021 Dec 31, 2019 $634.83M Feb 25, 2022
FY2020 Dec 31, 2018 $627.39M Feb 26, 2021
FY2019 Dec 31, 2017 $579.43M Feb 27, 2020
FY2018 Dec 31, 2016 $602.72M Feb 26, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($40.93M) Feb 27, 2026
FY2025 Dec 31, 2024 $1.84B Feb 27, 2026
FY2025 Dec 31, 2023 $1.26B Feb 27, 2026
FY2024 Dec 31, 2022 $798.04M Feb 26, 2025
FY2023 Dec 31, 2021 $1.20B Feb 27, 2024
FY2022 Dec 31, 2020 $343.50M Feb 27, 2023
FY2021 Dec 31, 2019 $199.00M Feb 25, 2022
FY2020 Dec 31, 2018 $10.77M Feb 26, 2021
FY2019 Dec 31, 2017 $259.23M Feb 27, 2020
FY2018 Dec 31, 2016 $406.72M Feb 26, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $34.46B Feb 27, 2026
FY2025 Dec 31, 2024 $32.68B Feb 27, 2026
FY2024 Dec 31, 2023 $30.25B Feb 26, 2025
FY2023 Dec 31, 2022 $27.68B Feb 27, 2024
FY2022 Dec 31, 2021 $27.37B Feb 27, 2023
FY2021 Dec 31, 2020 $25.88B Feb 25, 2022
FY2020 Dec 31, 2019 $25.60B Feb 26, 2021
FY2019 Dec 31, 2018 $24.13B Feb 27, 2020
FY2018 Dec 31, 2017 $24.76B Feb 26, 2019
FY2017 Dec 31, 2016 $20.81B Feb 28, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $28.11B Feb 27, 2026
FY2025 Dec 31, 2024 $26.59B Feb 27, 2026
FY2024 Dec 31, 2023 $24.99B Feb 26, 2025
FY2023 Dec 31, 2022 $23.04B Feb 27, 2024
FY2022 Dec 31, 2021 $21.96B Feb 27, 2023
FY2021 Dec 31, 2020 $20.58B Feb 25, 2022
FY2020 Dec 31, 2019 $20.06B Feb 26, 2021
FY2019 Dec 31, 2018 $19.10B Feb 27, 2020
FY2018 Dec 31, 2017 $19.42B Feb 26, 2019
FY2017 Dec 31, 2016 $14.54B Feb 28, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.36B Feb 27, 2026
FY2025 Dec 31, 2024 $6.09B Feb 27, 2026
FY2025 Dec 31, 2023 $5.26B Feb 27, 2026
FY2024 Dec 31, 2022 $4.64B Feb 26, 2025
FY2023 Dec 31, 2021 $5.41B Feb 27, 2024
FY2022 Dec 31, 2020 $5.30B Feb 27, 2023
FY2020 Dec 31, 2019 $5.54B Feb 26, 2021
FY2019 Dec 31, 2018 $5.03B Feb 27, 2020
FY2018 Dec 31, 2017 $5.34B Feb 26, 2019
FY2017 Dec 31, 2016 $6.27B Feb 28, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $66.50M Feb 27, 2026
FY2025 Dec 31, 2024 $66.50M Feb 27, 2026
FY2025 Dec 31, 2023 $100.80M Feb 27, 2026
FY2025 Dec 31, 2022 $100.80M Feb 27, 2026
FY2024 Dec 31, 2021 $100.80M Feb 26, 2025
FY2023 Dec 31, 2020 $100.80M Feb 27, 2024
FY2022 Dec 31, 2019 $102.00M Feb 27, 2023
FY2019 Dec 31, 2018 $102.00M Feb 27, 2020
FY2018 Dec 31, 2017 $102.00M Feb 26, 2019
FY2017 Dec 31, 2016 $47.15M Feb 28, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.18B Feb 27, 2026
FY2025 Dec 31, 2024 $7.34B Feb 27, 2026
FY2024 Dec 31, 2023 $6.44B Feb 26, 2025
FY2023 Dec 31, 2022 $6.25B Feb 27, 2024
FY2022 Dec 31, 2021 $6.20B Feb 27, 2023
FY2021 Dec 31, 2020 $5.76B Feb 25, 2022
FY2020 Dec 31, 2019 $6.06B Feb 26, 2021
FY2019 Dec 31, 2018 $5.91B Feb 27, 2020
FY2018 Dec 31, 2017 $5.98B Feb 26, 2019
FY2017 Dec 31, 2016 $6.53B Feb 28, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $820.25M Feb 27, 2026
FY2025 Dec 31, 2024 $2.14B Feb 27, 2026
FY2024 Dec 31, 2023 $953.48M Feb 26, 2025
FY2023 Dec 31, 2022 $751.42M Feb 27, 2024
FY2022 Dec 31, 2021 $844.59M Feb 27, 2023
FY2021 Dec 31, 2020 $902.83M Feb 25, 2022
FY2020 Dec 31, 2019 $1.24B Feb 26, 2021
FY2019 Dec 31, 2018 $1.23B Feb 27, 2020
FY2018 Dec 31, 2017 $948.63M Feb 26, 2019
FY2017 Dec 31, 2016 $1.04B Feb 28, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 12 Feb 27, 2026
FY2025 Dec 31, 2024 12 Feb 27, 2026
FY2025 Dec 31, 2023 4 Feb 27, 2026
FY2024 Dec 31, 2022 2 Feb 26, 2025
FY2023 Dec 31, 2021 6 Feb 27, 2024
FY2020 Dec 31, 2020 0 Feb 26, 2021
FY2020 Sep 30, 2020 0 Feb 26, 2021
FY2020 Jun 30, 2020 1 Feb 26, 2021
FY2020 Mar 31, 2020 (2) Feb 26, 2021
FY2020 Dec 31, 2019 0 Feb 26, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 12 Feb 27, 2026
FY2025 Dec 31, 2024 12 Feb 27, 2026
FY2025 Dec 31, 2023 4 Feb 27, 2026
FY2024 Dec 31, 2022 2 Feb 26, 2025
FY2023 Dec 31, 2021 6 Feb 27, 2024
FY2020 Dec 31, 2020 0 Feb 26, 2021
FY2020 Sep 30, 2020 0 Feb 26, 2021
FY2020 Jun 30, 2020 1 Feb 26, 2021
FY2020 Mar 31, 2020 (2) Feb 26, 2021
FY2020 Dec 31, 2019 0 Feb 26, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 74.14M Feb 27, 2026
FY2025 Dec 31, 2024 82.98M Feb 27, 2026
FY2024 Dec 31, 2023 85.29M Feb 26, 2025
FY2023 Dec 31, 2022 84.67M Feb 27, 2024
FY2022 Dec 31, 2021 84.77M Feb 27, 2023
FY2021 Dec 31, 2020 84.35M Feb 25, 2022
FY2020 Dec 31, 2019 83.96M Feb 26, 2021
FY2019 Dec 31, 2018 83.59M Feb 27, 2020
FY2018 Dec 31, 2017 83.16M Feb 26, 2019
FY2017 Dec 31, 2016 86.44M Feb 28, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $142.73M Feb 27, 2026
FY2025 Dec 31, 2024 $151.77M Feb 27, 2026
FY2025 Dec 31, 2023 $153.78M Feb 27, 2026
FY2024 Dec 31, 2022 $149.34M Feb 26, 2025
FY2023 Dec 31, 2021 $145.60M Feb 27, 2024
FY2022 Dec 31, 2020 $141.59M Feb 27, 2023
FY2021 Dec 31, 2019 $137.21M Feb 25, 2022
FY2020 Dec 31, 2018 $133.50M Feb 26, 2021
FY2019 Dec 31, 2017 $135.03M Feb 27, 2020
FY2018 Dec 31, 2016 $132.32M Feb 26, 2019